Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−6.66 USD
−17.55 M USD
1.51 M USD
About Kazia Therapeutics Limited
Sector
Industry
CEO
John E. Friend
Website
Headquarters
Sydney
Founded
1994
FIGI
BBG000KC7878
Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Sydney, Australia.
KZIA Good Risk:Reward RatioKZIA had a very large runup, and a pullback to Higher Low at 0.5637. Expecting a bounce from this level, to scale out of position up above @$1.02; $1.24 and $1.33 levels (Prior swing highs of the leg down). With the minimum risk:reward being 10:1, it is too good of opportunity to miss.
$KZIA looks good for a parabolic runLooks extremely bullish - definitely watching this stock. If price drops to $9, definitely a buy. Australia based firm has some key cancer drugs in the pipeline.
(1) Price above Kumo
(2) Future Kumo bullish
(3) Senkou span A & B with positive slope
(4) Both Tenkan Sen & Kijun Sen have +ve slopes
(5)
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.